Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Vaccher

Showing results (51-60 of 151) with videos related to

Pageof 16
Sort By:
JAMA|May 2, 1986
Heterosexual contact is not the predominant mode of HTLV-III transmission among intravenous drug abusersU Tirelli, E Vaccher, A Carbone, et al.
Infection|March 1, 1994
Clinical significance of positive direct antiglobulin test in patients with HIV infectionV De Angelis, C Biasinutto, P Pradella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patientsE Vaccher, U Tirelli, M Spina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1996
Destructive mucocutaneous phagedenic herpes simplex virus infection in an HIV-infected patient who had a partial response to interferon and ultraviolet raysG Giani, T Quirino, F Sacrini, et al.
Prostate Cancer and Prostatic Diseases|March 5, 2004
Mitoxantrone, vinorelbine and prednisone (MVD) in the treatment of metastatic hormonoresistant prostate cancer--a phase II trialD Bernardi, R Talamini, M Zanetti, et al.
Haematologica|March 1, 1988
Human immunodeficiency virus infection in transfused and untransfused cancer patients not belonging to known groups at increased risk for AIDSS Saracchini, U Tirelli, E Vaccher, et al.
Lancet (London, England)|April 5, 1986
Increased prevalence of HTLV-III antibody among drug addicts from Italian province with US military baseS Franceschi, U Tirelli, E Vaccher, et al.
The Journal of Clinical Investigation|August 15, 1997
Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infectionM Comar, C Simonelli, S Zanussi, et al.
Clinical Pharmacology and Therapeutics|August 24, 2007
Lopinavir-ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcomaG Corona, E Vaccher, S Sandron, et al.
Epidemiologia E Prevenzione|December 1, 1990
[Prevalence and determinants of HIV infection in 581 drug addicts in the Northeastern Italy, from 1984 to 1988]D Serraino, S Franceschi, E Vaccher, et al.
Pageof 16

Showing results (51-60 of 151) with videos related to

Sort By:
Pageof 16
JAMA|May 2, 1986
Heterosexual contact is not the predominant mode of HTLV-III transmission among intravenous drug abusersU Tirelli, E Vaccher, A Carbone, et al.
Infection|March 1, 1994
Clinical significance of positive direct antiglobulin test in patients with HIV infectionV De Angelis, C Biasinutto, P Pradella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patientsE Vaccher, U Tirelli, M Spina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1996
Destructive mucocutaneous phagedenic herpes simplex virus infection in an HIV-infected patient who had a partial response to interferon and ultraviolet raysG Giani, T Quirino, F Sacrini, et al.
Prostate Cancer and Prostatic Diseases|March 5, 2004
Mitoxantrone, vinorelbine and prednisone (MVD) in the treatment of metastatic hormonoresistant prostate cancer--a phase II trialD Bernardi, R Talamini, M Zanetti, et al.
Haematologica|March 1, 1988
Human immunodeficiency virus infection in transfused and untransfused cancer patients not belonging to known groups at increased risk for AIDSS Saracchini, U Tirelli, E Vaccher, et al.
Lancet (London, England)|April 5, 1986
Increased prevalence of HTLV-III antibody among drug addicts from Italian province with US military baseS Franceschi, U Tirelli, E Vaccher, et al.
The Journal of Clinical Investigation|August 15, 1997
Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infectionM Comar, C Simonelli, S Zanussi, et al.
Clinical Pharmacology and Therapeutics|August 24, 2007
Lopinavir-ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcomaG Corona, E Vaccher, S Sandron, et al.
Epidemiologia E Prevenzione|December 1, 1990
[Prevalence and determinants of HIV infection in 581 drug addicts in the Northeastern Italy, from 1984 to 1988]D Serraino, S Franceschi, E Vaccher, et al.
Pageof 16